6[1]Recchia FA,Bemstein RD,Sehgal PB,et al.Cytokines are a requisite part of the Pathophysiology Leading to Cardiac deeompensation[J].Proc Soc Exp Biol Med,2000,223(1):47-52.
7[2]Mann DL Recent insights into the role of tumor necrosis factor in the failure heart[J].Heart Fail Rw,2001,6(2):71-80.
8[3]Yilmaz MB,Guray U,Guyay Y,et al,Lipid profile of pa-tients with aortis stenosis mighf be predictive of rate of progression[J].Am Heart J,2004,147(5):761-763.
9[4]Sola s,Mir MQ,Lerakis S,et al,Atorvastatin improves Left Vetricular systolil function and serum Markers of inflam-marion in nonischemic heart failure[J].J Am Coll Cardiol,2006,47(2):332-337.
10[5]Tousoulis D,Antoniades C,Bosinakou E,et al,Effects of atorvastatin on reactive hyperemia and inflammatory pro-cess in patients with Congestive heart failure[J].Atheroscl-erosis,2005,178(2):359-363.
4ACQUATELLA H. Dilated cardiomyopathy: recent advances and current treatment [ J ]. Rev Esp Cardiol, 2000, 53 ( Suppl 1 ) : 19-27.
5TURPEINEN A K,VANNINEN E, MAGGA J,et al. Cardiac sympathetic activity is associated with inflammation and neurohumoral activation in patients with idiopathic dilated cardiomyopathy [ J ]. Clin Physiol Funct Imaging, 2009,29 (6) : 414-419.
6DOBREK L,THOR P. Neuroendocrine aetivation as a target of modem chronic heart failure pharmaeotherapy [ J ]. Acta Pol Pharm,2011,68(3) : 307-316.
7YAGI H,TOYAMA T, KASAMA S, et al. Relation between connective tissue growth factor and cardiac sympathetic nerve activity in heart failure in DCM patients[ J]. Int Heart J,2012,53(5) : 282-286.
8CRUICKSHANK J M. Beta-blockers and heart failure [ J ]. Indian Heart J,2010,62(2) : 101-110.
9KURUM T,TATLI E, YUKSEL M. Effects of carvedilol on plasma levels of pro-inflammatory eytokines in patients with ischemic and nonischemie dilated cardiomyopathy [ J ]. Tex Heart Inst J,2007,34( 1 ) : 52-59.
10NIKITIN N P, ALYAVI A L, GOLOSKOKOVA V Y. Benefit of long-term treatment with metoprolol in patients with dilated cardiomyopathy receiving enalapril: focus on the pattern of left ventricular diastolic filling [ J ]. Cardiovasc Drugs Ther, 1999,13 ( 3 ) : 271-273.
